Biocryst Pharmaceuticals reported $13.66M in Stock for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Adamas Pharmaceuticals ADMS:US 8.68M 892K
Alexion Pharmaceuticals ALXN:US $ 803.9M 28.2M
Alnylam Pharmaceuticals ALNY:US $ 110.95M 26.59M
Biocryst Pharmaceuticals BCRX:US $ 13.66M 3.82M
Chugai Pharma 4519:JP Y 201421M 2258M
Daiichi Sankyo 4568:JP Y 209990M 1818M
Gilead Sciences GILD:US $ 2797M 191M
GlaxoSmithKline GSK:LN 6244M 86M
Intra Cellular Therapies ITCI:US $ 8.17M 0.4M
IONIS PHARMACEUT IONS:US $ 22.93M 1.17M
Karyopharm Therapeutics KPTI:US $ 3.94M 38K
Neurocrine Biosciences NBIX:US $ 25.5M 2.8M
Novavax NVAX:US $ 0 0
Ptc Therapeutics PTCT:US $ 15.61M 0.83M
Regeneron Pharmaceuticals REGN:US $ 1550.1M 433.8M
Ultragenyx Pharmaceutical RARE:US $ 15.19M 0.11M
Vertex Pharmaceuticals VRTX:US $ 333.46M 11.84M
YTE INCY:US $ 21.3M 4.63M
Zogenix ZGNX:US $ 3.5M 0.58M